Evidence map›Paper›PMID 35087155›Full record

ArticleScientific reports2022

Phasic firing of dopaminergic neurons in the ventral tegmental area triggers peripheral immune responses.

Tasuku Kayama, Yuji Ikegaya, Takuya Sasaki

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Tasuku KayamaGraduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, 113-0033, Japan.
Yuji IkegayaGraduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, 113-0033, Japan.
Takuya SasakiGraduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, 113-0033, Japan. takuya.sasaki.b4@tohoku.ac.jp.
The University of Tokyo · JP

Funding

Japan Agency for Medical Research and Development 1041630; JP21zf0127004Japan Science and Technology Agency JPMJER1801Japan Society for the Promotion of Science 19H04897; 17H05939; 20H03545
6 · The paper itself

Abstract

Dopaminergic neurons in the ventral tegmental area (VTA) play a crucial role in the processing of reward-related information. Recent studies with pharmacological manipulations of VTA neuronal activity demonstrated a VTA-induced immunoenhancement in peripheral organs. Here, to examine the detailed physiological dynamics, we took an optogenetic approach in which VTA dopaminergic neurons were selectively activated with millisecond precision. Optogenetic phasic, rather than tonic, stimulation of VTA dopaminergic neurons increased serum cytokine levels, such as IL-2, IL-4 and TNF-α. These results provide direct evidence to link dopaminergic neuronal phasic firing to peripheral immunity. Next, we tested whether cytokine induction in male mice was boosted by female encounters, a natural condition that induces increased active VTA neurons and gamma power. Female encounters increased serum IL-2 levels, which were abolished by pharmacological inhibition of VTA neuronal activity. Taken together, our results highlight the importance of the brain reward system in the treatment and management of immune-related disorders.

Indexed as

Immunity, HumoralAnimalsBehavior, AnimalDopaminergic NeuronsElectric StimulationInterleukin-2Interleukin-4MaleMiceOptogeneticsSignal TransductionStereotaxic TechniquesTumor Necrosis Factor-alphaVentral Tegmental AreaIl4 protein, mouseInterleukin-2Interleukin-4Tnf protein, mouseTumor Necrosis Factor-alpha

Identifiers

PMID35087155
PMCPMC8795439
OpenAlexW4210671960

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.